Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2021 Feb 9;2021:3179693. doi: 10.1155/2021/3179693

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang 1, HuaGe Zhong 1, YuZhou Qin 1, WeiYuan Wei 1, Zhao Li 1, MingWei Huang 1,, XiaoLing Luo 2,
PMCID: PMC7902123  PMID: 33644226

In the article titled “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma” [1], there are errors in both the grant number and the funder name stated in the Acknowledgements section, which should be updated as follows:

“We sincerely appreciate TCGA (https://cancergenome.nih.gov/) and UCSC Xena (http://xena.ucsc.edu/) for sharing the GC data and for Dr Liucheng Wu for his advice with the language consulting of the manuscript. The study was supported by the National Natural Science Foundation of GuangXi (No. 2019GXNSFBA185041) and National Natural Science Foundation of China (No. 81760521).”

Contributor Information

MingWei Huang, Email: mingweihuang1@163.com.

XiaoLing Luo, Email: luoxiaoling67@126.com.

References

  • 1.Wang T. A., Zhong H. G., Qin Y. Z., et al. ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma. BioMed Research International. 2020;2020:16. doi: 10.1155/2020/3575038.3575038 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES